ロード中...
Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma
Renal cell carcinoma (RCC) is a common malignancy worldwide with approximately 95,000 new cases per year and ranks as the sixth cause of cancer deaths. Until recently, the slightly active and very toxic cytokines were available for patients with advanced RCC. Advances have been made in understanding...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2011
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3818940/ https://ncbi.nlm.nih.gov/pubmed/24198638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OAJU.S7230 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|